Podcast: Download (Duration: 1:06 — 1.5MB)

Subscribe: RSS

You may have heard of a new blood test for Alzheimer’s disease just approved by the FDA. Abhay Moghakar, a neurologist and blood biomarkers expert at Johns Hopkins, says even if you are older and have symptoms of the disease, …

People who develop dementia as they age most often have a mixed type, Elizabeth Tracey reports Read more »

Podcast: Download (Duration: 1:06 — 1.5MB)

Subscribe: RSS

A new blood test for Alzheimer’s disease isn’t a stand alone diagnostic tool. That’s according to Abhay Moghekar, a blood biomarkers expert and a neurologist at Johns Hopkins. Moghekar: You would still need the clinical input in the context of …

A truly comprehensive test for Alzheimer’s disease may be on the horizon, Elizabeth Tracey reports Read more »

Podcast: Download (Duration: 1:04 — 1.5MB)

Subscribe: RSS

Will an FDA cleared blood test for Alzheimer’s disease ease or complicate diagnosis? Clearly in approving the test the FDA hopes for the former, yet the complete picture is more complex than that, says Abhay Moghekar, a blood biomarkers expert …

Biomarkers alone don’t mean Alzheimer’s disease is present, Elizabeth Tracey reports Read more »

Podcast: Download (Duration: 1:05 — 1.5MB)

Subscribe: RSS

Positive results on the newly FDA cleared blood test for Alzheimer’s disease don’t necessarily mean you have the disease. That’s according to blood biomarkers expert Abhay Moghekar, a neurologist at Johns Hopkins. Moghekar: Whether that's the cause of your cognitive …

If you get a positive result on the new blood test for Alzheimer’s disease, what does that mean? Elizabeth Tracey reports Read more »

Podcast: Download (Duration: 1:03 — 1.4MB)

Subscribe: RSS

The FDA has just cleared a blood test to help make the diagnosis of Alzheimer’s disease, which otherwise may require some fairly invasive methods. Blood biomarkers expert Abhay Moghekar, a neurologist at Johns Hopkins, says the test looks for the …

Who is a candidate for the new blood test for Alzheimer’s disease? Elizabeth Tracey reports Read more »

Podcast: Download (Duration: 1:05 — 1.5MB)

Subscribe: RSS

A blood test to screen for proteins related to Alzheimer’s disease has been cleared by the FDA, and it’s designed for people who are older than 55 years of age and have cognitive symptoms. Johns Hopkins neurologist Abhay Moghekar, a …

What’s the basis of the new blood test to screen for Alzheimer’s disease? Elizabeth Tracey reports Read more »